State Street Corp Oramed Pharmaceuticals Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, State Street Corp holds 60,056 shares of ORMP stock, worth $138,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,056

Previous 59,260 1.34%

Holding current value

$138,729

Previous $152,000 3.95%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.21 - $2.63 $1,759 - $2,093	796 Added 1.34%	60,056 $146,000
Q2 2024 Aug 14, 2024	BUY	$2.07 - $2.83 $2,334 - $3,192	1,128 Added 1.94%	59,260 $152,000
Q1 2024 May 15, 2024	BUY	$2.18 - $3.58 $344 - $565	158 Added 0.27%	58,132 $169,000
Q4 2023 Feb 14, 2024	BUY	$1.71 - $2.57 $1,983 - $2,981	1,160 Added 2.04%	57,974 $133,000
Q3 2023 Nov 14, 2023	BUY	$2.51 - $3.55 $3,795 - $5,367	1,512 Added 2.73%	56,814 $148,000
Q2 2023 Aug 14, 2023	BUY	$2.12 - $4.47 $3,044 - $6,418	1,436 Added 2.67%	55,302 $197,000
Q1 2023 May 15, 2023	BUY	$1.93 - $13.1 $5,544 - $37,636	2,873 Added 5.63%	53,866 $117,000
Q4 2022 Feb 14, 2023	BUY	$5.88 - $12.03 $23,525 - $48,132	4,001 Added 8.51%	50,993 $613,000
Q3 2022 Nov 15, 2022	BUY	$4.6 - $9.91 $4,521 - $9,741	983 Added 2.14%	46,992 $305,000
Q2 2022 Aug 15, 2022	SELL	$3.72 - $9.0 $1.83 Million - $4.42 Million	-491,661 Reduced 91.44%	46,009 $211,000
Q1 2022 May 16, 2022	BUY	$8.19 - $13.89 $208,222 - $353,139	25,424 Added 4.96%	537,670 $4.65 Million
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $314,726 - $721,348	24,247 Added 4.97%	512,246 $7.32 Million
Q3 2021 Nov 15, 2021	BUY	$12.13 - $23.82 $1.65 Million - $3.24 Million	136,079 Added 38.67%	487,999 $10.7 Million
Q2 2021 Aug 16, 2021	BUY	$8.34 - $14.59 $2.94 Million - $5.13 Million	351,920 New	351,920 $4.71 Million

Others Institutions Holding ORMP

# of Institutions

Shares Held

7.4M

Call Options Held

Put Options Held

2.1K

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $89.7M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Oramed Pharmaceuticals Inc. Transaction History